lobbying_activities: 2018986

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2018986	802352db-c6d1-423c-894c-95109fca8074	3T	KNIGHT CAPITOL CONSULTANTS	40036301	BRAEBURN PHARMACEUTICALS, INC.	2017	third_quarter	HCR	Controlled Substances Act provisions relating to the distribution of medication assisted therapies (The Protecting Patient Access to Emergency Medications Act, S. 916/H.R. 304. Adequacy of funding for opioid overuse disorder (OUD) treatment in the Affordable Care Act Repeal/Replace legislation.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	1	2017-09-29T13:33:43.683000-04:00